Real-life experience of rare hepatoid adenocarcinomas of the lung: A large retrospective french cohort.

被引:0
|
作者
Fave, Thomas
Quere, Gilles
Robinet, Gilles
Babey, Helene
Renaud, Emmanuelle
Dhamelincourt, Estelle
Nguyen, Jessica
Amah, Arnaud Simaki
Basse, Victor
Descourt, Renaud
Geier, Margaux
机构
[1] CHRU Morvan Brest, Brest, France
[2] CHRU Brest, Hop Morvan, Brest, France
[3] CHU Brest, Brest, France
[4] Ctr Oncol St Yves, Vannes, France
[5] Hosp Morvan, Thorac Oncol Dept, Brest, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21091
引用
收藏
页数:1
相关论文
共 50 条
  • [21] TREATMENT OF AXIAL SPONDYLOARTHRITIS WITH SECUKINUMAB: A REAL-LIFE RETROSPECTIVE COHORT STUDY
    Smiljanic Tomicevic, L.
    Padjen, I.
    Martinic, M.
    Mayer, M.
    Anic, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1706 - 1706
  • [22] Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study
    Ratzinger, Franz
    Panic, Tanja
    Haslacher, Helmuth
    Perkmann, Thomas
    Schmetterer, Klaus G.
    Belik, Sabine
    Maenner, Georg
    Pabinger, Ingrid
    Quehenberger, Peter
    BIOCHEMIA MEDICA, 2017, 27 (03) : 522 - 534
  • [23] Efficacy of topical tacrolimus for oral lichen planus: real-life experience in a retrospective cohort of patients with a review of the literature
    Ribero, S.
    Stieger, M.
    Quaglino, P.
    Hongang, T.
    Bornstein, M. M.
    Naldi, L.
    Borradori, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1107 - 1113
  • [24] Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort.
    Kauffman-Ortega, Eric
    Ruiz-Manriquez, Jesus
    Olivas-Martinez, Antonio
    Campos-Murguia, Alejandro
    Flores-Garcia, Nayelli C.
    Marquez-Guillen, Ernesto
    Lopez-Yanez, Silvia
    Sanchez-avila, Francisco
    Toapanta-Yanchapaxi, Liz
    Paez-Zayas, Victor M.
    Garcia-Juarez, Ignacio
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (07) : 713 - 718
  • [25] Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real-life experience from a French cohort (2019-2023)
    Frange, P.
    Veber, F.
    Burgard, M.
    Blanche, S.
    Avettand-Fenoel, V.
    HIV MEDICINE, 2024, 25 (02) : 299 - 305
  • [26] Identifying the ideal MitraClip candidate - a COAPT-derived, retrospective subgroup stratification of a large real-life cohort
    Tigges, E.
    Kalbacher, D. K.
    Gossling, A. G.
    Ludwig, S. L.
    Schofer, N. S.
    Conradi, L. C.
    Schirmer, J. S.
    Girdauskas, E. G.
    Reichenspurner, H. R.
    Blankenberg, S. B.
    Lubos, E. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1071 - 1071
  • [27] The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study
    Raciti, Loredana
    De Luca, Rosaria
    Raciti, Gianfranco
    Arcadi, Francesca Antonia
    Calabro, Rocco Salvatore
    MEDICAL SCIENCES, 2022, 10 (03)
  • [28] Regorafenib in recurrent glioblastoma patients: A large real-life experience.
    Caccese, Mario
    Cerretti, Giulia
    Padovan, Marta
    Zagonel, Vittorina
    Lombardi, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Five years' real-life experience with raltegravir in a large HIV centre
    van Halsema, Clare
    Whitfield, Thomas
    Lin, Naomi
    Ashton, Kathryn
    Torkington, Adele
    Ustianowski, Andrew
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (05) : 387 - 393
  • [30] Outcome of childhood ALK-positive anaplastic large cell lymphoma relapses: Real-life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children
    Pereira, Victor
    Barthoulot, Mael
    Aladjidi, Nathalie
    Contet, Audrey
    Dalle, Jean-Hugues
    Dourthe, Marie emilie
    Garnier, Nathalie
    Bruno, Benedicte
    Leruste, Amaury
    Pellier, Isabelle
    Simonin, Matthieu
    Paillard, Catherine
    Verschuur, Arnauld
    Ducassou, Stephane
    Lamant, Laurence
    Brugieres, Laurence
    Deley, Marie-Cecile Le
    Rigaud, Charlotte
    PEDIATRIC BLOOD & CANCER, 2025, 72 (01)